GyreOx Therapeutics Seed
1 known investors
Gyre Therapeutics is a biopharmaceutical company developing drug candidates such as F351 (hydronidone) for the treatment of liver fibrosis, including CHB-induced liver fibrosis.
Investors · 1
Frequently asked questions
- What does GyreOx Therapeutics Seed do?
- Gyre Therapeutics is a biopharmaceutical company developing drug candidates such as F351 (hydronidone) for the treatment of liver fibrosis, including CHB-induced liver fibrosis.
- Who are GyreOx Therapeutics Seed's investors?
- GyreOx Therapeutics Seed's investors include Future Planet Capital.